Cargando…

Safety of Influenza Vaccination Among Hospitalized Patients

BACKGROUND: Despite national recommendations, hospital influenza vaccination rates remain low. To address potential concerns regarding safety, we evaluated whether influenza vaccinatioqinPn during hospitalization increases utilization and/or evaluations for infection post-discharge. METHODS: This re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tartof, Sara, Liu, In-Lu Amy, Qian, Lei, Lewin, Bruno, Sy, Lina S, Tseng, Hung Fu, Hechter, Rulin, Jacobsen, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631380/ http://dx.doi.org/10.1093/ofid/ofx163.1150

Ejemplares similares

Pneumococcal Conjugate Vaccine Safety in Elderly Adults
por: Tseng, Hung Fu, et al.
Publicado: (2018)

Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization
por: Hechter, Rulin C., et al.
Publicado: (2017)

2284. Ten-Year Effectiveness of Live Virus Herpes Zoster Vaccine
por: Tseng, Hung Fu, et al.
Publicado: (2018)

19. Completion of Two-Dose Recombinant Zoster Vaccine Series in Adults 50 Years and Older
por: Tseng, Hung-Fu, et al.
Publicado: (2020)

115. Post-licensure Safety Study of New-onset Immune-mediated Diseases, Herpes Zoster, and Anaphylaxis in Adult Recipients of HepB-CPG Vaccine Versus HepB-alum Vaccine
por: Ackerson, Bradley, et al.
Publicado: (2022)

1551. Changes in Glomerular Filtration Rate after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
por: Rivera, Adovich, et al.
Publicado: (2023)

286. Hepatitis B Vaccine Compliance: Comparing 2-Dose and 3-Dose Vaccines
por: Bruxvoort, Katia, et al.
Publicado: (2019)

1163. Influenza Vaccination Coverage through December among Persons Ages Six Months and Older in the Vaccine Safety Datalink, 2017-18 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

1874. Prior Screening for Latent Tuberculosis among Patients Diagnosed with Active Tuberculosis: Missed Opportunities?
por: Garba, Saadiq, et al.
Publicado: (2023)

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

80. COVID-19 Testing, Characteristics, and Outcomes Among People Living with HIV in an Integrated Health System
por: Chang, Jennifer J, et al.
Publicado: (2020)

1156. Real-World Effectiveness of Recombinant Zoster Vaccine in Chinese Adults Aged ≥50 Years in the US
por: Florea, Ana, et al.
Publicado: (2023)

Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012–13, 2013–14, and 2014–15
por: Donahue, James G., et al.
Publicado: (2019)

LB20. Impact of School-Located Influenza Vaccination on Vaccination Coverage, School Absenteeism, and Influenza Hospitalization
por: Benjamin-Chung, Jade
Publicado: (2018)

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
por: Hanson, Kayla E, et al.
Publicado: (2019)

1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults
por: Ackerson, Bradley, et al.
Publicado: (2019)

917. Development and Validation of an Automated Natural Language Processing Method for Identifying Postherpetic Neuralgia from Electronic Health Records
por: Zheng, Chengyi, et al.
Publicado: (2023)

2554. Safety and Immunogenicity of NasoVAX, a Novel Intranasal Influenza Vaccine
por: Tasker, Sybil, et al.
Publicado: (2018)

784. Real-world effectiveness of the mRNA-12733-dose primary series against COVID-19 in an immunocompromised population Interim results from a prospective observational cohort study
por: Ku, Jennifer H, et al.
Publicado: (2022)

A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
por: Irving, Stephanie A., et al.
Publicado: (2022)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

2461. Safety of Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid-Conjugate Vaccine in Adolescents
por: Myers, Tanya, et al.
Publicado: (2018)

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018
por: Silveira, Fernanda P, et al.
Publicado: (2019)

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

2742. The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010–2017
por: Klein, Eili, et al.
Publicado: (2019)

Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons
por: E Segaloff, Hannah, et al.
Publicado: (2017)

Challenges in Phase 4 post-licensure safety studies using real world data in the United States: Hepatitis B vaccine example
por: Bruxvoort, Katia, et al.
Publicado: (2021)

2739. Comparison of Hemagglutination Antibody Inhibition (HAI) Titers Following Influenza Vaccination by Birth Cohort and Repeated Influenza Vaccination History
por: Sherman, Amy C, et al.
Publicado: (2019)

22. Description of Hospitalized Patients with Influenza Vaccine Failure
por: Kimball, Joanna, et al.
Publicado: (2020)

Serums and Vaccines in Influenza
Publicado: (1919)

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
por: Lewnard, Joseph A., et al.
Publicado: (2023)

990. Impact of Influenza Vaccination Setting on Timing of Vaccination in a National Sample of Influenza-Vaccinated Adults
por: Luther, Megan
Publicado: (2018)

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016
por: Alyanak, Elif, et al.
Publicado: (2018)

2741. Seasonal Influenza Vaccine Timing in Children and Adults Hospitalized with Influenza in the United States, FluSurv-NET, 2013–2017
por: Haston, Julia C, et al.
Publicado: (2019)

2833. Multi-drug resistance of Escherichia coli from outpatient uncomplicated urinary tract infections in a large U.S. integrated health care organization
por: Ku, Jennifer H, et al.
Publicado: (2023)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

2638. Patterning of high-risk comorbidity associated with vaccination but not influenza status among hospitalized patients in an influenza test-negative design cohort
por: Leis, Aleda M, et al.
Publicado: (2023)

Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study
por: Xu, Stanley, et al.
Publicado: (2023)

2300. Incidence, Complications, and Recurrence of Herpes Zoster in Unvaccinated Adults ≥50 Years of Age
por: Ackerson, Bradley, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r92m29u9rkismcfkikh7s5gqc1